The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 07, 2024
Filed:
Nov. 04, 2019
Applicant:
Zeda Biopharmaceuticals, Inc., Shenzhen, CN;
Inventors:
Yu Xia, Zhongshan, CN;
Zhongmin Wang, Zhongshan, CN;
Peng Zhang, Zhongshan, CN;
Baiyong Li, Zhongshan, CN;
Assignee:
ZEDA BIOPHARMACEUTICALS, INC., Shenzhen, CN;
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/24 (2006.01); A61K 39/395 (2006.01); A61P 37/00 (2006.01); C12N 5/10 (2006.01); C12N 15/00 (2006.01); C12N 15/13 (2006.01); A61K 39/00 (2006.01); C12N 5/00 (2006.01); C12N 15/09 (2006.01); C12N 15/63 (2006.01);
U.S. Cl.
CPC ...
C07K 16/245 (2013.01); A61P 37/00 (2018.01); A61K 39/395 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/33 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); C12N 5/00 (2013.01); C12N 15/09 (2013.01); C12N 15/63 (2013.01); C12N 2502/99 (2013.01);
Abstract
Provided are antibodies or antigen binding fragments thereof, which can bind to human IL-1β, block the binding of IL-1β to receptors thereof and thereby down regulate the activity of IL-1β, and can be used to prepare drugs for the treatment of immune diseases mediated by IL-1β overexpression such as arthritis, osteoporosis, and tumor necrosis factor receptor-associated periodic syndrome.